PT85149A - Process for the preparation oh human monoclonal antibodies to lymphadenopathy-associated virus - Google Patents

Process for the preparation oh human monoclonal antibodies to lymphadenopathy-associated virus

Info

Publication number
PT85149A
PT85149A PT85149A PT8514987A PT85149A PT 85149 A PT85149 A PT 85149A PT 85149 A PT85149 A PT 85149A PT 8514987 A PT8514987 A PT 8514987A PT 85149 A PT85149 A PT 85149A
Authority
PT
Portugal
Prior art keywords
monoclonal antibodies
human monoclonal
lav
htlv
iii
Prior art date
Application number
PT85149A
Other languages
English (en)
Other versions
PT85149B (pt
Inventor
Janela Mcclure
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of PT85149A publication Critical patent/PT85149A/pt
Publication of PT85149B publication Critical patent/PT85149B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT85149A 1986-06-23 1987-06-23 Processo para a preparacao de anticorpos monoclonais humanos para o virus associado com linfadenopatia PT85149B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87757986A 1986-06-23 1986-06-23

Publications (2)

Publication Number Publication Date
PT85149A true PT85149A (en) 1987-07-01
PT85149B PT85149B (pt) 1990-07-31

Family

ID=25370267

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85149A PT85149B (pt) 1986-06-23 1987-06-23 Processo para a preparacao de anticorpos monoclonais humanos para o virus associado com linfadenopatia

Country Status (12)

Country Link
EP (1) EP0251612B1 (pt)
JP (1) JP2626680B2 (pt)
KR (1) KR910001808B1 (pt)
AT (1) ATE103002T1 (pt)
AU (1) AU614714B2 (pt)
CA (1) CA1339830C (pt)
DE (1) DE3789333T2 (pt)
DK (1) DK169582B1 (pt)
ES (1) ES2050114T3 (pt)
IE (1) IE63109B1 (pt)
IL (1) IL82926A (pt)
PT (1) PT85149B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
EP0355140B1 (en) * 1987-11-13 1996-03-20 KATINGER, Hermann Human monoclonal anti-hiv-i-antibodies
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US5298419A (en) * 1988-03-31 1994-03-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
EP0418347A4 (en) * 1989-02-28 1994-12-14 Univ New York Human monoclonal antibodies to human immunodeficiency virus
US5731189A (en) * 1989-02-28 1998-03-24 New York University Human monoclonal antibodies to human immunodeficiency virus
WO1990010457A1 (en) * 1989-03-14 1990-09-20 New York University Method of treating hiv infections using immunotoxins
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
DE19809785C2 (de) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmunpharmakon zur Behandlung der HIV-1-Infektion
US6680209B1 (en) * 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
WO2005115992A1 (en) 2004-05-23 2005-12-08 Housey Pharmaceuticals, Inc. Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
JP2019509046A (ja) 2015-12-05 2019-04-04 サントル オスピタリエ ユニヴェルシテール ヴォドアＣｅｎｔｒｅ Ｈｏｓｐｉｔａｌｉｅｒ Ｕｎｉｖｅｒｓｉｔａｉｒｅ Ｖａｕｄｏｉｓ Ｈｉｖ結合剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520113A (en) 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
AU8127187A (en) * 1986-12-03 1988-06-09 Ici Australia Operations Proprietary Limited Mine roof supporting element

Also Published As

Publication number Publication date
IL82926A (en) 1991-07-18
DK169582B1 (da) 1994-12-12
IE871587L (en) 1987-12-23
ES2050114T3 (es) 1994-05-16
IL82926A0 (en) 1987-12-20
JPS63107998A (ja) 1988-05-12
DK304087A (da) 1987-12-24
AU7451287A (en) 1987-12-24
DK304087D0 (da) 1987-06-15
IE63109B1 (en) 1995-03-22
KR910001808B1 (ko) 1991-03-26
CA1339830C (en) 1998-04-21
EP0251612A3 (en) 1990-05-23
PT85149B (pt) 1990-07-31
EP0251612A2 (en) 1988-01-07
EP0251612B1 (en) 1994-03-16
DE3789333T2 (de) 1994-07-07
DE3789333D1 (de) 1994-04-21
JP2626680B2 (ja) 1997-07-02
ATE103002T1 (de) 1994-04-15
AU614714B2 (en) 1991-09-12
KR880000585A (ko) 1988-03-28

Similar Documents

Publication Publication Date Title
PT85149A (en) Process for the preparation oh human monoclonal antibodies to lymphadenopathy-associated virus
EP0674178A3 (en) Cyclosporin immunoassay.
FI860015A (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
EP0231914A3 (en) Htlv-iii envelope peptides
DE3379116D1 (en) Immunoassay method
KR100215606B1 (en) Toxoplasma gondii antigens, the preparation thereof and the diagnostic agent containing them
PT71169A (en) Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE96675T1 (de) Spezifische sekretions-exkretions-antigene von toxoplasma gondii, deren expressionsprodukte, verfahren zu deren herstellung und deren diagnostische und prophylaktische anwendungen.
AU2865084A (en) Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
CN105807056A (zh) 检测高效氯氟氰菊酯残留的试纸卡
IL83047A0 (en) Monoclonal antibodies to pseudomonas aerigunosa flagella,method and cell line for their production and pharmaceutical compositions containing them
ZA873922B (en) Method of preparation and use for feline leukemia virus antigens
JPS55141452A (en) Synthetic polypeptide
BE888855A (fr) Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues
AU1042488A (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
IL58662A0 (en) Process for the preparation of unsaturated ethers
JPS5244229A (en) Method of making serological reagent for syphilis
GB8822393D0 (en) Method for production of antigenic proteinhapten conjugates & antibodies corresponding thereto
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.
JPS57106691A (en) Novel glyceroglycolipid compound and its preparation
JPS5270017A (en) Novel method for immono-assay
Pallesen Concentrating of antibodies against leucosis in bulk milk(by a dialysis-system) for examination in an ELISA-system.
Veynblat et al. Methods used in preparation and purification of capsular antigen and endotoxin of plague pathogen.
SE8305667L (sv) Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990731